WEST CHESTER, Ohio--(BUSINESS WIRE)--Oct. 29, 2015--
AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for
atrial fibrillation (Afib) and left atrial appendage management, today
announced that it will present at the Stifel Healthcare Conference at
the Palace Hotel in New York City on Wednesday, November 18, 2015.
Management is scheduled to present at 2:15 p.m. Eastern Time. A live
audio webcast of the presentation may be accessed by visiting the
Investors page of AtriCure’s corporate website at www.atricure.com.
A replay of the presentation will be available for 90 days following the
presentation.
AtriCure management is also scheduled to present at the Canaccord
Medical Technologies & Diagnostics Forum at the Westin Grand Central in
New York City on Thursday, November 19, 2015. Management is scheduled to
present at 1:00 p.m. Eastern Time. A live audio webcast of the
presentation may be accessed by visiting the Investors page of
AtriCure’s corporate website at www.atricure.com.
A replay of the presentation will be available for 90 days following the
presentation.
About AtriCure, Inc.
AtriCure, Inc. is a medical device company providing innovative atrial
fibrillation (Afib) solutions designed to produce superior outcomes that
reduce the economic and social burden of atrial fibrillation. AtriCure’s
Synergy™ Ablation System is the first and only surgical device approved
for the treatment of persistent and longstanding persistent forms of
Afib in patients undergoing certain open concomitant procedures.
AtriCure’s AtriClip left atrial appendage management (LAAM) exclusion
device is the most widely sold device worldwide that’s indicated for the
occlusion of the left atrial appendage. The company believes
cardiothoracic surgeons are adopting its ablation and LAAM devices for
the treatment of Afib and reduction of Afib related complications such
as stroke. Afib affects more than 33 million people worldwide.For
more information visit AtriCure.com
or follow us on Twitter @AtriCure.
View source version on businesswire.com: http://www.businesswire.com/news/home/20151029006531/en/
Source: AtriCure, Inc.
AtriCure, Inc.
Andy Wade
Senior Vice President and
Chief Financial Officer
513-755-4564
awade@atricure.com
or
Investor
Relations
Westwicke Partners
Lynn Pieper
415-202-5678
lynn.pieper@westwicke.com
